Autologous mesenchymal stem cell therapy for diabetic men with erectile dysfunction. Is it promising? A pilot study
Archivio Italiano di Urologia e Andrologia • 2023
Publication Information
Authors
Mohamed A. Alhefnawy; Emad Salah;Sayed Bakry; Taymour M. Khalifa;Alaa Rafaat;Refaat Hammad;Ali Sobhy;Ahmed Wahsh
Keywords
Erectile dysfunction; Diabetes; Stem cell.
Journal
Archivio Italiano di Urologia e Andrologia
Publisher
Not Available
Volume
95
Issue
4
Pages
1-5
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Purpose: to assess safety and efficacy of
autologous mesenchymal bone marrow stem
cell injection in penile cavernosal tissue for erectile dysfunction
therapy in diabetic men.
Methods: The subjects of this study were diabetic men suffering
erectile dysfunction, non-responding to maximum dose of oral
PDE5I. Mesenchymal bone marrow stem cells were aspirated
and injected after preparation in both corpora cavernosa at 3, 9
o’clock position. Erectile function was assessed by the
International Index of Erectile Function and penile Doppler
study, before and after 6 months after injection.
Results: 4 patients out of 10 achieve hard erection adequate for
satisfactory coitus, and 2 patients achieved penile hardness
with addition of pharmacological therapy with sildenafil
100mg. Peak systolic velocity increased significantly in 4
patients (2 arteriogenic and 2 mixed erectile dysfunction), from
12∼22 cm/s to 32∼69 cm/s. Variations in end-diastolic velocity
increased substantially in 2 patients with venogenic insufficien-
cy alone at follow-up from 4∼5 cm /s to -4∼-3 cm/s.
Conclusions: Despite promising stem cell treatment efficacy for
patients with erectile dysfunction, more clinical studies and
researches are still warranted.
autologous mesenchymal bone marrow stem
cell injection in penile cavernosal tissue for erectile dysfunction
therapy in diabetic men.
Methods: The subjects of this study were diabetic men suffering
erectile dysfunction, non-responding to maximum dose of oral
PDE5I. Mesenchymal bone marrow stem cells were aspirated
and injected after preparation in both corpora cavernosa at 3, 9
o’clock position. Erectile function was assessed by the
International Index of Erectile Function and penile Doppler
study, before and after 6 months after injection.
Results: 4 patients out of 10 achieve hard erection adequate for
satisfactory coitus, and 2 patients achieved penile hardness
with addition of pharmacological therapy with sildenafil
100mg. Peak systolic velocity increased significantly in 4
patients (2 arteriogenic and 2 mixed erectile dysfunction), from
12∼22 cm/s to 32∼69 cm/s. Variations in end-diastolic velocity
increased substantially in 2 patients with venogenic insufficien-
cy alone at follow-up from 4∼5 cm /s to -4∼-3 cm/s.
Conclusions: Despite promising stem cell treatment efficacy for
patients with erectile dysfunction, more clinical studies and
researches are still warranted.
Staff Members - Benha University